Taiwo, B. O., Zheng, L., Stefanescu, A., Nyaku, A., Bezins, B., Wallis, C. L., . . . Gulick, R. M. (2018). ACTG A5353: A Pilot Study of Dolutegravir Plus Lamivudine for Initial Treatment of Human Immunodeficiency Virus-1 (HIV-1)–infected Participants With HIV-1 RNA <500000 Copies/mL. Clin Infect Dis.
Citação norma ChicagoTaiwo, Babafemi O., et al. "ACTG A5353: A Pilot Study of Dolutegravir Plus Lamivudine for Initial Treatment of Human Immunodeficiency Virus-1 (HIV-1)–infected Participants With HIV-1 RNA <500000 Copies/mL." Clin Infect Dis 2018.
MLA CitationTaiwo, Babafemi O., et al. "ACTG A5353: A Pilot Study of Dolutegravir Plus Lamivudine for Initial Treatment of Human Immunodeficiency Virus-1 (HIV-1)–infected Participants With HIV-1 RNA <500000 Copies/mL." Clin Infect Dis 2018.